BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22530942)

  • 21. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
    Ataga KI; Cappellini MD; Rachmilewitz EA
    Br J Haematol; 2007 Oct; 139(1):3-13. PubMed ID: 17854302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulmonary hypertension in an adult sickle cell population in Guadeloupe.
    Billy-Brissac R; Blanchet-Deverly A; Etienne-Julan M; Foucan L
    Int J Cardiol; 2009 Jun; 135(1):122-3. PubMed ID: 18466988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology and treatment of sickle cell disease.
    Raphael RI
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):492-505. PubMed ID: 16167028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron in sickle cell disease: a review why less is better.
    Koduri PR
    Am J Hematol; 2003 May; 73(1):59-63. PubMed ID: 12701123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Big strokes in small persons.
    Adams RJ
    Arch Neurol; 2007 Nov; 64(11):1567-74. PubMed ID: 17998439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion in the patient with sickle cell disease: a critical review of the literature and transfusion guidelines.
    Josephson CD; Su LL; Hillyer KL; Hillyer CD
    Transfus Med Rev; 2007 Apr; 21(2):118-33. PubMed ID: 17397762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy insight: metabolic and endocrine disorders in sickle cell disease.
    Smiley D; Dagogo-Jack S; Umpierrez G
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):102-9. PubMed ID: 18212812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress in β-thalassaemia and sickle cell disease.
    Voskou S; Aslan M; Fanis P; Phylactides M; Kleanthous M
    Redox Biol; 2015 Dec; 6():226-239. PubMed ID: 26285072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal permeability pathways in human red blood cells.
    Ellory JC; Robinson HC; Browning JA; Stewart GW; Gehl KA; Gibson JS
    Blood Cells Mol Dis; 2007; 39(1):1-6. PubMed ID: 17434766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic disarrangement in ischemic heart disease and its therapeutic control.
    Ferrari R
    Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Abnormal autonomic cardiovascular responses in patients with sickle cell anemia].
    Romero-Vecchione E; Pérez O; Wessolosky M; Rosa F; Liberatore S; Vásquez J
    Sangre (Barc); 1995 Oct; 40(5):393-9. PubMed ID: 8553174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
    Connes P; Machado R; Hue O; Reid H
    Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversibility of splenic function by transfusion in two young adults with sickle cell anemia.
    Wethers DL; Grover R
    Am J Pediatr Hematol Oncol; 1987; 9(3):209-11. PubMed ID: 3674332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.
    Machado RF; Gladwin MT
    Br J Haematol; 2005 May; 129(4):449-64. PubMed ID: 15877728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current issues in blood transfusion for sickle cell disease.
    Wahl S; Quirolo KC
    Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sickle cell disease-related organ damage occurs irrespective of pain rate: implications for clinical practice.
    van Beers EJ; van Tuijn CF; Mac Gillavry MR; van der Giessen A; Schnog JJ; Biemond BJ;
    Haematologica; 2008 May; 93(5):757-60. PubMed ID: 18367483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
    Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
    Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal and hepatic complications of sickle cell disease.
    Ebert EC; Nagar M; Hagspiel KD
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):483-9; quiz e70. PubMed ID: 20215064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
    Hebbel RP; Osarogiagbon R; Kaul D
    Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary complications of sickle cell disease in children.
    Caboot JB; Allen JL
    Curr Opin Pediatr; 2008 Jun; 20(3):279-87. PubMed ID: 18475096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.